Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Metastatic GIST With C-KIT Exon 17 Mutation
NCT02606097Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Apr 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in gastrointestinal stromal tumor (GIST), sponsored by Chang Gung Memorial Hospital. Started Apr 2014; status: completed.
02
Drugs
regorafenib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02606097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606097.